Skip to main content

Song Hong Fang's Form 4 filing

CG Oncology, Inc. (CGON) · filed Jan 31, 2024

Accession no.
0000950170-24-009429
Filed
Jan 31, 2024
Trade date
Jan 29, 2024
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 4 derivative transactions. Open-market purchases total $5.00M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Song Hong FangCIK 0002008157Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 29, 2024Common StockCConversionAcquired+350,771––350,771Direct
Jan 29, 2024Common StockCConversionAcquired+1,011,192––1,011,192Indirect
Jan 29, 2024Common StockCConversionAcquired+3,930,176––3,930,176Indirect
Jan 29, 2024Common StockPPurchaseAcquired+263,157$19.00+$4,999,983613,928Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 29, 2024Common StockCConversionDisposed−350,771––0Direct
Jan 29, 2024Common StockCConversionDisposed−656,839––0Indirect
Jan 29, 2024Common StockCConversionDisposed−354,353––0Indirect
Jan 29, 2024Common StockCConversionDisposed−3,930,176––0Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)